Impact of body mass index (BMI) on efficacy and safety of abemaciclib in breast cancer patients (pts) treated in the monarchE trial.

Basit Öğe Kaydı
dc.contributor.authorDesmedt, Christine
dc.contributor.authorBorgquist, Signe
dc.contributor.authorGarcia-Estevez, Laura
dc.contributor.authorMartin, Miguel
dc.contributor.authorJohnston, Stephen R. D.
dc.contributor.authorCardoso, Fatima
dc.contributor.authorBrufsky, Adam
dc.date.accessioned2026-04-04T13:33:05Z
dc.date.available2026-04-04T13:33:05Z
dc.date.issued2025
dc.departmentİnönü Üniversitesi
dc.description.abstract[No abstract available]
dc.description.sponsorshipEli Lilly and Company
dc.description.sponsorshipEli Lilly and Company
dc.identifier.doi10.1200/JCO.2025.43.16_suppl.520
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue16_SUPPL
dc.identifier.orcid0000-0002-5223-5579
dc.identifier.urihttps://doi.org/10.1200/JCO.2025.43.16_suppl.520
dc.identifier.urihttps://hdl.handle.net/11616/108906
dc.identifier.volume43
dc.identifier.wosWOS:001608775300001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofJournal of Clinical Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250329
dc.titleImpact of body mass index (BMI) on efficacy and safety of abemaciclib in breast cancer patients (pts) treated in the monarchE trial.
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu